Interactions between neomycin and cerebral dopaminergic and serotoninergic transmission in rats

A el Ayadi1, M Errami

  • 1Department of Biology, Abdelmalek Essaâdi University, Morocco.

Therapie
|February 10, 2000
PubMed

Insights

Neomycin significantly alters dopamine and serotonin levels in rat brains, impacting neurotransmitter balance. This study reveals neomycin

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Monoamine neurotransmitters like dopamine and serotonin are crucial for brain function.
  • Neomycin is an antibiotic with potential neurological side effects that require investigation.

Purpose of the Study:

  • To investigate the impact of neomycin administration on monoamine levels in rat striatal tissue.
  • To elucidate the effects of neomycin on dopamine and serotonin pathways in the brain.

Main Methods:

  • Rats were administered neomycin (2 mg/kg; i.p.) and observed over 24 hours.
  • Striatal tissue homogenates were analyzed using High-Performance Liquid Chromatography (HPLC) with electrochemical detection.
  • Levels of dopamine, serotonin, and their metabolites were quantified.

Main Results:

  • Neomycin caused a significant increase in striatal dopamine levels (+35%) and a decrease in its metabolite levels (-36%).
  • Striatal serotonin levels increased significantly (+130%) within 2 hours post-injection.
  • Ratios of DOPAC/DA and 5HIAA/5HT were reduced, indicating altered neurotransmitter metabolism.

Conclusions:

  • Neomycin exerts an inhibitory effect on both dopaminergic and serotoninergic systems in the rat striatum.
  • Potential mechanisms include altered biosynthesis via enzyme stimulation (tyrosine hydroxylase, tryptophan hydroxylase) or modified enzyme activity (MAO, COMT).
  • Calcium channel blockade is also suggested as a possible mechanism for neomycin's neurochemical effects.

Related Concept Videos

Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...